Open tibial fractures grade IIIC treated successfully with external fixation, negative-pressure wound therapy and recombinant human bone morphogenetic protein 7

International Wound Journal

Volumn 11, Issue 5, 2014, Pages 476-482

  Babiak, Ireneusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

NPWT; Open tibial fracture grade IIIC; RhBMP 7; V.A.C. therapy

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1; OSTEOGENIC PROTEIN 1;

ADULT; ARTICLE; BONE TISSUE; CASE REPORT; COMMINUTED FRACTURE; DIAPHYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FIBULA FRACTURE; FRACTURE EXTERNAL FIXATION; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; ILIZAROV EXTERNAL FIXATOR; MALE; OPEN FRACTURE; PERSISTENT INFECTION; PRIORITY JOURNAL; SOFT TISSUE; SOFT TISSUE DEFECT; SPLIT THICKNESS SKIN GRAFT; TIBIA FRACTURE; VACUUM ASSISTED CLOSURE; VACUUM ASSISTED CLOSURE DEVICE; WOUND CLOSURE; EXTERNAL FIXATOR; FRACTURE FIXATION; FRACTURES, OPEN; RETROSPECTIVE STUDY; SOFT TISSUE INJURIES; TIBIAL FRACTURES; TREATMENT OUTCOME; WOUND HEALING;

ADULT; BONE MORPHOGENETIC PROTEIN 7; EXTERNAL FIXATORS; FEMALE; FRACTURE FIXATION; FRACTURES, OPEN; HUMANS; MALE; NEGATIVE-PRESSURE WOUND THERAPY; RETROSPECTIVE STUDIES; SOFT TISSUE INJURIES; TIBIAL FRACTURES; TREATMENT OUTCOME; WOUND HEALING;

EID: 84927911062     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.01112.x     Document Type: Article

References (35)

1. Behrens F, Searls K. External fixation of the tibia. Basic concepts and prospective evaluation. J Bone Joint Surg Br 1986;68:246-54.
2. Okike K, Bhattacharyya T. Trends in the management of open fractures. J Bone Joint Surg Am 2006;88:2739-48.
3. Bach AW, Hansen ST. Plates versus external fixation in severe open tibial shaft fractures: A randomized trial. Clin Orthop Relat Res 1989;241:89-94.
4. Tornetta P 3rd, Bergman M, Watnik N, Berkowitz G, Steuer J. Treatment of grade IIIB open tibial fractures: A prospective randomized comparison of external fixation and non-reamed locked nailing. J Bone Joint Surg Br 1994;76:13-9.
5. Finkemeier CG, Schmidt AH, Kyle RF, Templeman DC, Varecka TF. A prospective, randomized study of intramedullary nails inserted with and without reaming for treatment of open and closed fractures of the tibial shaft. J Orthop Trauma 2000;14:187-93.
6. Yokoyama K, Itoman M, Uchino M, Fukushima K, Nitta H, Kojima Y. Immediate versus delayed intramedullary nailing for open fractures of the tibial shaft: a multivariate analysis of factors affecting deep infection and fracture healing. Indian J Orthop 2008;42:410-9.
7. Gopal S, Majumder S, Batchelor AG, Knight SL, De Boer P, Smith RM. Fix and flap: the radical orthopedic and plastic treatment of severe open fractures of the tibia. J Bone Joint Surg Br 2000;82:959-66.
8. Hutson J, Dayicioglu D, Oeltjen J, Panthaki Z, Armstrong M. The treatment of Gustilo grade IIIB tibia fractures with application of antibiotic spacer, flap, and sequential distraction osteogenesis. Ann Plast Surg 2010;64:541-52.
9. Kostiuchenko II, Kolker VA, Karlov VA. The vacuum effect in the surgical treatment of purulent wounds. Vestnik Khirurgii 1986;9:18-21.
10. Davydov YA, Larichev KG, Abramov AY. Concepts for clinical biological management of the wound process in the treatment of purulent wounds using vacuum therapy. Vestnik Khirugii 1991;2:132-5.
11. Morykwas MJ, Argenta LC, Shelton-Brown El, McGuirt W. Vacuum-assisted closure: a new method for wound control end treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553-62.
12. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control end treatment: clinical experience. Ann Plast Surg 1997;38:563-77.
13. Zoch G. Das Prinzip der vakuumunterstutzten Wundbehandlung. Eur Surg 2003;35(Suppl):3-5.
14. ® Therapy Canadian Consensus Group. A consensus report on the use of vacuum-assisted closure in chronic, difficult-to-heal wounds. Ostomy Wound Manage 2003;49:52-66.
15. Kaufman WSM, Pahl DW. Vaccum-assisted closure therapy: wound care and nursing implications. Dermatol Nurs 2003;15:317-25.
16. Stannard J. Complex orthopaedic wounds: prevention and treatment with negative pressure wound therapy. Orthop Nurs 2004;23:1-6.
17. Labler L, Keel M, Trentz O. VAC-Wundverband zur temporaren Weichteildeckung bei drittgradig offenen Frakturen der unteren Extremitat. Eur Surg 2003;35:(Suppl):10-11.
18. Stannard J, Singanamala N, Volgas DA. Fix and flap in the era of vacuum suction devices: What do we know in terms of evidence based medicine?. Injury 2010;41:780-6.
19. Chen D, Zhao M, Mundy G. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.
20. Ristiniemi J, Flinkkilä T, Hyvönen P, Lakovaara M, Pakarinen H, Jalovaara P. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J Bone Joint Surg 2007;89-B:265-72.
21. Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, Jones A, Kregor PJ, Nordsletten L, Paiement G, Patel A. Recombinant Human Bone Morphogenetic Protein-2 in Open Tibial Fractures: A Subgroup Analysis of Data Combined from Two Prospective Randomized Studies. J Bone Joint Surg Am 2006;88:1258-1265.
22. ®)) in the treatment of tibial fracture non-unions. An overview of the use in Belgium. Acta Orthop Belg 2008;74:534-7.
23. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 2005;36(4 Suppl):51-9.
24. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 2001;83-A(Suppl pt 2):151-8.
25. Giannoudis P, Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury 2005;36(3 Suppl):47-50.
26. Cook SD, Barrack RL, Santman M, Patron LP, Salkeld SL, Whitecloud TS. Strut allograft healing to the femur with recombinant human osteogenic protein-1. Clin Orthop 2000;381:47-57.
27. ® bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg 1999;81-B:710-8.
28. Govender S, Csimma C, Genent HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A:2123-34.
29. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX. BMP-2 Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study Group. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg 2006;88-A:1431-41.
30. Nauth A, Ristiniemi J, McKee MD, Schemitsch E. Bone morphogenetic proteins in open fractures: past, present and future. Injury, Int J Care Injured 2009;40:27-31.
31. Birke-Sorensen H, Malmsjo M, Rome P, Hudson D, Krug E, Berg L, Bruhin A, Caravaggi C, Chariker M, Depoorter M, Dowsett C, Dunn R, Duteille F, Ferreira F, Martinez JMF, Grudzien G, Ichioka S, Ingemansson R, Jeffery S, Lee C, Vig S, Runkel N, Martin R, Smith J. Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer) -steps toward an international consensus. J Plast Reconstr Aesthet Surg 2011;64:1-16.
32. Dahabreh Z, Calori GM, Kanakaris NK, Giannoudis PV. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int Orthop 2009;33:1407-14.
33. Alt V, Donell ST, Chhabra A, Bentley A. A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany and France. Injury, Int J Care Injured 2009;40:1269-75.
34. Górecki A, Babiak I. Infection of joint prosthesis and local drug delivery. In: Kienapfel H, Kühn K-D, editors The infected implant. Berlin-Heidelberg: Springer-Verlag GmbH, 2009:19-26.
35. Murphy PS, Evans GD. Advances in wound healing: a review of current wound healing products. Plast Surg Int 2012;2012:190436. Epub.